FDA 483 - Sinsin Pharmaceutical Co., Ltd. - December 13, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Sinsin Pharmaceutical Co., Ltd. in Ansan-Si, Gyeonggi-Do, Korea, a drug product manufacturer, was cited for significant deficiencies in quality control, data integrity, and equipment cleaning during an FDA inspection. The firm failed to thoroughly investigate discrepancies and complaints, maintain secure electronic data systems, and adequately document equipment cleaning, with some issues being repeat observations. These findings indicate a serious lack of adherence to cGMP regulations.
ID · b6103018-c4b6-428e-b78e-a6f20e581a31